@simonfleclerc

Nephrologist and Researcher at Maisonneuve-Rosemont Hospital. Focusing on glomerular diseases, podocytes and autoimmunity.

 Montreal, Quebec, Canada
linkedin.com/in/simon-leclerc-45b819227/
Joined April 2011
  • Tweets9
  • Following56
  • Followers29
Replying to @ISNWCN @SayaliBThakare @tomokotakano2 @YokoShirai_twmu @Glomkeeper @simonfleclerc @DrSumanBehera @Aubodah @drsusansamuel @mallorydownie @Dr_RatnaSamanta @allisondart7 @drpriyajohn @priti899 @GabyNeph @DrAkshayaJ @deniise_am @AnandhUrmila @acssjr @nephromythri @myadla @hhlwu @elbaonelida @NephroSeeker @iamnephrologist @thtrm @dr_ali20007 @Arunkr_Dr @Alexgr23 @dra_miliflores @EhabHafiz2 @DrBarbaTeba @DrMedhavi_G
"Nephrin trafficking in a mouse model of experimental autoimmune nephrotic syndrome," by Soichiro Suzuki et al, was awarded with the #ISNWCN the Smart Kidney: top scored abstract. Visual abstract by @HarukaM_5, available for download here: bit.ly/40vAg3d
2
7
17
473
Replying to @ISNWCN @SayaliBThakare @tomokotakano2 @YokoShirai_twmu @Glomkeeper
"Extrafollicular B cells and anti-slit diaphragm autoantibodies underly a shared autoimmune pathogenesis in childhood and adult idiopathic podocytopathies," by @simonfleclerc et al, was awarded with #ISNWCN Best Abstract Scored. VA by @DrSumanBehera bit.ly/40vAg3d
1
7
14
433
Simon Leclerc retweeted
Suman Behera@DrSumanBeheraMar 26
Congratulations to @tomokotakano2 and the research team @simonfleclerc @Aubodah @drsusansamuel @mallorydownie @Dr_RatnaSamanta @allisondart7 on the best abstract award at #WCN26 โ€‹๐Ÿ‘๏ธ ๐Ÿ‘‡ Check out all of the excellent visual abstracts: theisn.org/wcn/media/visual-โ€ฆ
8
1
17
1,271
Replying to @ISNkidneycare @vjha126 @kellumja @RonGansevoort
๐—ช๐—–๐—ก'๐Ÿฎ๐Ÿฒ ๐—•๐—ฒ๐˜€๐˜ ๐—”๐—ฏ๐˜€๐˜๐—ฟ๐—ฎ๐—ฐ๐˜ ๐—”๐˜„๐—ฎ๐—ฟ๐—ฑ๐˜€: ๐Ÿ‡จ๐Ÿ‡ฆ @simonfleclerc ๐Ÿ‡ฏ๐Ÿ‡ต Naoyuki Shimada ๐Ÿ‡ฏ๐Ÿ‡ต @YokoShirai_twmu Awarded to the top three abstracts selected by the #ISNWCN Abstract committee
1
4
6
653
๐—ช๐—–๐—ก'๐Ÿฎ๐Ÿฒ ๐—•๐—ฒ๐˜€๐˜ ๐—”๐—ฏ๐˜€๐˜๐—ฟ๐—ฎ๐—ฐ๐˜ ๐—”๐˜„๐—ฎ๐—ฟ๐—ฑ๐˜€: ๐Ÿ‡จ๐Ÿ‡ฆ @simonfleclerc ๐Ÿ‡ฏ๐Ÿ‡ต Naoyuki Shimada ๐Ÿ‡ฏ๐Ÿ‡ต @YokoShirai_twmu Awarded to the top three abstracts selected by the #ISNWCN Abstract committee
1
4
6
445
Simon Leclerc retweeted
CJKHD@CanJKHD12 Oct 2022
Bridging Gaps in Diabetic Nephropathy Care: A Narrative Review Guided by the Lived Experiences of Patient Partners โฆ@CanJKHDโฉ โฆ@CSNSCNโฉ journals.sagepub.com/doi/10.โ€ฆ

Bridging Gaps in Diabetic Nephropathy Care: A Narrative Review Guided by the Lived Experiences of...

Purpose of review: Diabetes affects almost a 10th of the Canadian population, and diabetic nephropathy is one of its main complications. It remains a leading ca...

journals.sagepub.com
2
1
4
Simon Leclerc retweeted
JASN_News@JASN_News23 Aug 2022
Research into the cause of podocyte injury in idiopathic nephrotic syndrome (INS) is limited by the lack of animal models mediated by autoimmunity. This mouse model of INS makes anti-Crb2 autoantibodies & has severe proteinuria bit.ly/j2022010070 @simonfleclerc
Visual Abstract for the article titled "A Novel Mouse Model of Idiopathic Nephrotic Syndrome Induced by Immunization with the Podocyte Protein Crb2."

ALT Visual Abstract for the article titled "A Novel Mouse Model of Idiopathic Nephrotic Syndrome Induced by Immunization with the Podocyte Protein Crb2."

2
1
7
First published article as the last author !! #clinicianscientist #newinvestigator โ˜บ๏ธ pubmed.ncbi.nlm.nih.gov/3441โ€ฆ

Cellular therapies in kidney transplantation - PubMed

Emerging data underline that cell therapy is a feasible and safe treatment in kidney transplantation. Although the evidence points to a benefit for transplant recipients, studies with standardized...

pubmed.ncbi.nlm.nih.gov
1
2
7
Simon Leclerc retweeted
AJKD@AJKDonline6 Jul 2021
Minimal Change Disease With Severe Acute Kidney Injury Following the Oxford-AstraZeneca COVID-19 Vaccine: A Case Report buff.ly/3jPSoAK (FREE) @virginieroyal @lamarchecaroli1 #COVID19 #AKI
5
19
Load more